Stay updated on Nivolumab With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T17:40:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Locations section now includes Texas; the old label 'Texas Locations' has been removed. Updated the footer to revision v3.3.3 and removed the 'HHS Vulnerability Disclosure' line.
    Difference
    0.2%
    Check dated 2025-12-23T08:20:03.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. This appears to be an administrative version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2025-12-01T16:54:02.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Publications section updated to clarify that entries are automatically filled from PubMed, and the page template revision is noted (additions: v3.3.1; deletions: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:07:54.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Funding-status notice about lapses in government funding has been removed from the page, reducing visibility of site-wide operating status for users viewing this study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:26:50.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    No significant changes to core study content, design, arms, outcomes, or eligibility criteria were detected; observed differences are limited to minor text formatting and an updated last-modified timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:13:34.000Z thumbnail image

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.